Comparison of Hyalomatrix and Integra Wound Matrix on Burn Wounds
NCT ID: NCT02363543
Last Updated: 2017-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2016-02-29
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Clinical Evaluation of an Esterified Hyaluronic Acid Matrix in Burn Patients for STSG
NCT03723590
Comparison of Skin Substitutes Used in Burn Care
NCT00676013
A Study to Evaluate the Efficacy of Cytal® Burn Matrix in the Management of Partial-Thickness Burns to the Hand
NCT03598023
Compare the Efficacy of Mepilex and Keramatrix in Second Degree Burn Wounds
NCT01790763
Single-Stage Integra Reconstruction in Burns
NCT03077087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hyalomatrix
Sterile, single use, flexible, and conformable wound dressing comprised of a derivative of hyaluronic acid which acts as a three dimensional regenerative matrix.
Hyalomatrix
Integra
Sterile, single use, wound care dressing comprised of a porous matrix of cross-linked bovine tendon collagen and glycosaminoglycan
Integra
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyalomatrix
Integra
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* First and/or second degree burns on both hands
* Subject must be enrolled within 48 hours of the injury occurrence.
Exclusion Criteria
* Subject has a prognosis that indicates unlikely survival past the study period.
* Subject's diagnosis indicates third degree burns.
* Subject suffers from burns sustained as a result of an electrical/chemical injury or by frostbite.
* Subject suffers from any inhalation-related burn trauma.
* Subject suffers from ongoing bone fractures.
* Subject has a known sensitivity to materials containing silicone, hyaluronan, bovine collagen, or chondroitin and/or derivatives of these products.
* Subject has received any treatment prior to study enrollment that may, in the opinion of the Investigator, affect the outcome of the study.
* Subject suffers from a medical condition that may impede wound healing, above any beyond that which would typically be expected.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medline Industries
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R14-090
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.